Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

CorrigendumCardiology Free access | 10.1172/JCI23073C1

PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury

Tomohisa Nagoshi, Takashi Matsui, Takuma Aoyama, Annarosa Leri, Piero Anversa, Ling Li, Wataru Ogawa, Federica del Monte, Judith K. Gwathmey, Luanda Grazette, Brian Hemmings, David A. Kass, Hunter C. Champion, and Anthony Rosenzweig

Find articles by Nagoshi, T. in: JCI | PubMed | Google Scholar

Find articles by Matsui, T. in: JCI | PubMed | Google Scholar

Find articles by Aoyama, T. in: JCI | PubMed | Google Scholar

Find articles by Leri, A. in: JCI | PubMed | Google Scholar

Find articles by Anversa, P. in: JCI | PubMed | Google Scholar

Find articles by Li, L. in: JCI | PubMed | Google Scholar

Find articles by Ogawa, W. in: JCI | PubMed | Google Scholar

Find articles by del Monte, F. in: JCI | PubMed | Google Scholar

Find articles by Gwathmey, J. in: JCI | PubMed | Google Scholar

Find articles by Grazette, L. in: JCI | PubMed | Google Scholar

Find articles by Hemmings, B. in: JCI | PubMed | Google Scholar

Find articles by Kass, D. in: JCI | PubMed | Google Scholar

Find articles by Champion, H. in: JCI | PubMed | Google Scholar

Find articles by Rosenzweig, A. in: JCI | PubMed | Google Scholar

Published February 1, 2006 - More info

Published in Volume 116, Issue 2 on February 1, 2006
J Clin Invest. 2006;116(2):548–548. https://doi.org/10.1172/JCI23073C1.
© 2006 The American Society for Clinical Investigation
Published February 1, 2006 - Version history
View PDF

Related article:

PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury
Tomohisa Nagoshi, … , Hunter C. Champion, Anthony Rosenzweig
Tomohisa Nagoshi, … , Hunter C. Champion, Anthony Rosenzweig
Research Article Cardiology

PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury

  • Text
  • PDF
Abstract

Acute activation of the serine-threonine kinase Akt is cardioprotective and reduces both infarction and dysfunction after ischemia/reperfusion injury (IRI). However, less is known about the chronic effects of Akt activation in the heart, and, paradoxically, Akt is activated in samples from patients with chronic heart failure. We generated Tg mice with cardiac-specific expression of either activated (myristoylated [myr]) or dominant-negative (dn) Akt and assessed their response to IRI in an ex vivo model. While dn-Akt hearts demonstrated a moderate reduction in functional recovery after IRI, no function was restored in any of the myr-Akt–Tg hearts. Moreover, infarcts were dramatically larger in myr-Akt–Tg hearts. Biochemical analyses demonstrated that chronic Akt activation induces feedback inhibition of PI3K activity through both proteasome-dependent degradation of insulin receptor substrate–1 (IRS-1) and inhibition of transcription of IRS-1 as well as that of IRS-2. To test the functional significance of these signaling changes, we performed in vivo cardiac gene transfer with constitutively active PI3K in myr-Akt–Tg mice. Restoration of PI3K rescued function and reduced injury after IRI. These data demonstrate that PI3K-dependent but Akt-independent effectors are required for full cardioprotection and suggest a mechanism by which chronic Akt activation can become maladaptive.

Authors

Tomohisa Nagoshi, Takashi Matsui, Takuma Aoyama, Annarosa Leri, Piero Anversa, Ling Li, Wataru Ogawa, Federica del Monte, Judith K. Gwathmey, Luanda Grazette, Brian Hemmings, David A. Kass, Hunter C. Champion, Anthony Rosenzweig

×

Original citation: J Clin Invest. 2005;115(8):2128–2138. doi:10.1172/JCI23073.

Citation for this corrigendum: J Clin Invest. 2006;116(2):548. doi:10.1172/JCI23073C1.

In the original author list, Brian A. Hemmings’s name appeared incorrectly. The corrected author list appears above.

The authors regret this error.

Version history
  • Version 1 (February 1, 2006): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts